Navigation Links
AbbVie to Present at Cowen 35th Annual Health Care Conference
Date:2/25/2015

NORTH CHICAGO, Ill., Feb. 25, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Cowen 35th Annual Health Care Conference on Wednesday, March 4, 2015. Bill Chase, executive vice president and chief financial officer, will make a presentation on the company and participate in a question and answer session at 9 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations Web site at www.abbvieinvestor.com.  An archived edition of the session will be available later that day.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs more than 26,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.


'/>"/>
SOURCE AbbVie
Copyright©2015 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Revised GAAP earnings guidance for AbbVie Inc for the Financial Year ending December 31, 2014 and Third Quarter ending September 30, 2014; Confirms Adjusted Earnings Guidance
2. AbbVie And Calico Announce A Novel Collaboration To Accelerate The Discovery, Development And Commercialization Of New Therapies
3. AbbVie Announces Inaugural Week of Possibilities Volunteer Program to Support Six Schools in North Chicago, Ill., and Worcester, Mass.
4. AbbVie and North Chicago Public Schools Announce $350,000 Grant to Advance Math Education
5. AbbVie to Present at Jefferies 2013 Healthcare Conference
6. AbbVie to Present at Credit Suisse 2013 Healthcare Conference
7. AbbVie to Present at Morgan Stanley Global Healthcare Conference
8. Vote to Help Award a $21,000 AbbVie CF Scholarship to Two Inspirational Students with Cystic Fibrosis Pursuing their Goals of Higher Education
9. AbbVie Presents Results from Phase I Study of Investigational Oncology Compound ABT-199 at American Society of Clinical Oncology Annual Meeting
10. StockCall Scrutinizes Pfizer, Merck & Co., Johnson & Johnson, and AbbVie
11. GenomeDxs Decipher Shows Broad Applicability in Advancing Prostate Cancer Care in Data Presented at 2015 ASCO Genitourinary Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia ... therapy technology (“3LT®”), today announces that the U.S. Food and Drug Administration (FDA) ... laser for the temporary relief of chronic neck and shoulder pain of musculoskeletal ...
(Date:10/3/2019)... ... October 02, 2019 , ... Murrieta Genomics , the ... and venture capital companies in Silicon Valley at a special Life Science showcase ... will be held at the JJ Lake Business Center located at 340 E. Middlefield ...
(Date:9/24/2019)... (PRWEB) , ... September 24, ... ... be presenting their latest research in the area of high-level X-ray methods ... Dr. Pamela Smith, COO of Improved Pharma, will present “Synchrotron X-Ray Diffraction ...
(Date:9/24/2019)... ... September 24, 2019 , ... In the past three years, the National ... at South Dakota School of Mines & Technology that expands human understanding ... surfaces to form a slimy and yet strong layer which is commonly known as ...
Breaking Biology Technology:
(Date:10/4/2019)... ... 2019 , ... Representatives with MyBioGate ( https://events.mybiogate.com/ ) announced ... Hamburg Rothenbaumchaussee in Hamburg. , “To better connect Chinese companies and European markets, ... of Operations and spokesperson for MyBioGate. , Guo went on to highlight that ...
(Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a ... FDA approved clinical trial for stem cell treatment of knee osteoarthritis . The successful ... as a subsidiary of VetStem Biopharma. , PSC CEO, Michael Dale, stated, “We are ...
(Date:9/30/2019)... Calif. (PRWEB) , ... September 30, 2019 , ... ... consulting firm focused on increasing the capacity of life science organizations to accelerate ... in San Francisco, CA on October 4th. , What: Just 30 days to ...
Breaking Biology News(10 mins):